Mobile

A Randomised, Double-blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects with Moderately-to Severely Active Crohn’s Disease

Mise à jour : Il y a 4 ans
Référence : EUCTR2010-022382-10

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

• To assess the efficacy of GSK1605786A compared with placebo as an induction therapy in subjects with moderately-to-severely active Crohn’s disease over 12 weeks.

Critère d'inclusion

  • Subjects with Moderately-to-Severely Active Crohn’s Disease

Liens